Aethlon Medical

AEMD

5.4703.01% ( +0.160 )

Closed: Nov 6, 16:00:00 (EDT)

Current ValuationThe current P/E ratio is -1.23, below the reasonable range, cheaper than 80.81% of the time in the past 5 years, and the industry ranks 92/173, the industry Median -0.79.

-1.23xP/E

Stock price$5.31Earnings per share$-4.32

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

014284256

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

0x30x60x90x120x150x

P/E ratio
Name/Symbol
BAXUSBaxter	-18.35x	166.27%	$13.27B
GKOSUSGlaukos	-76.42x	90.98%	$12.98B
TFXUSTeleflex	-6.25x	118.39%	$6.45B
IRTCUSIRhythm	-307.70x	53.96%	$4.29B
PLSEUSPulse Biosciences	-47.28x	26.85%	$3.79B
AXGNUSAxogen	-89.60x	12.42%	$2.86B
ASSTUSStrive	-2.62x	57.99%	$2.55B
KMTSUSKestra Medical Tech	-11.16x	0.79%	$1.67B
ENOVUSEnovis	-3.13x	100.97%	$1.65B
BFLYUSButterfly Network	-30.24x	36.13%	$1.62B
NVCRUSNovocure	-13.01x	13.66%	$1.58B
TNDMUSTandem Diabetes	-19.77x	77.60%	$1.25B
AORTUSArtivion	-387.02x	266.67%	$1.23B
DRTSUSAlpha Tau Medical	-13.27x	--	$1.23B
ATECUSAlphatec	-13.93x	51.67%	$1.21B
PRCTUSPROCEPT BioRobotics	-10.11x	3.47%	$1.16B
SIBNUSSI-BONE	-79.48x	23.19%	$1.09B
CBLLUSCeribell	-13.67x	39.53%	$1.01B
QDELUSQuidelOrtho	-2.38x	75.33%	$880.51M
BBNXUSBeta Bionics	-10.13x	13.23%	$842.15M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.